IDENTIFICATION OF RISK FACTORS FOR POSTOPERATIVE ACUTE SEVERE PAIN IN ABDOMINAL SURGERY.

Culegere de Rezumate Stiinţifice a Congresului SRATI 2012: AL 38-LEA CONGRES AL SOCIETĂŢII ROMÂNE DE ANESTEZIE ŞI TERAPIE INTENSIVĂ; AL 6-LEA CONGRES ROMÂNO - FRANCEZ DE ANESTEZIE ŞI TERAPIE INTENSIVĂ; AL 4-LEA SIMPOZION ROMÂNO - ISRAELIAN DE ACTUALITĂŢI ÎN ANESTEZIE ŞI TERAPIE INTENSIVĂ; AL 11-LEA CONGRES AL ASISTENŢILOR DE ANESTEZIE ŞI TERAPIE INTENSIVĂ; AL 10-LEA CONGRES AL SOCIETĂŢII ROMÂNE DE SEPSISIntroducere: În pofida măsurilor luate, prevalenţa durerii postoperatorii acute intense, DPOI (≥5/10 pe SVN) rămâne înaltă (24- 46% – în Europa de Vest şi 64% – în Republica Moldova). Strategiile preventive pentru DPOI trebuie să ia în consideraţie şi factorii de risc. Scopul lucrării: Identificarea factorilor de risc pentru DPOI după intervenţii pe abdomen (herniorafie, apendectomie, colecistectomie) prin screening-ul unor condiţii pre- şi intraoperatorii suspecte. Introduction: Despite recent acivements, the prevalence of postoperative acute severe pain, PASP (≥5/10, VNS) is high (24-46% – in West European countries and 64% – in Republic of Moldova). Prevention strategies for PASP should take into account the risk factors. Goal of the Study: Identification of risk factors for PASP after abdominal surgery (hernioplasty, appendectomy, cholecystectomy) via screening of some intra- and postoperative suspected conditions

Intraoperative transfusion practices in Europe

BACKGROUND: Transfusion of allogeneic blood influences outcome after surgery. Despite widespread availability of transfusion guidelines, transfusion practices might vary among physicians, departments, hospitals and countries. Our aim was to determine the amount of packed red blood cells (pRBC) and blood products transfused intraoperatively, and to describe factors determining transfusion throughout Europe. METHODS: We did a prospective observational cohort study enrolling 5803 patients in 126 European centres that received at least one pRBC unit intraoperatively, during a continuous three month period in 2013. RESULTS: The overall intraoperative transfusion rate was 1.8%; 59% of transfusions were at least partially initiated as a result of a physiological transfusion trigger- mostly because of hypotension (55.4%) and/or tachycardia (30.7%). Haemoglobin (Hb)- based transfusion trigger alone initiated only 8.5% of transfusions. The Hb concentration [mean (sd)] just before transfusion was 8.1 (1.7) g dl(-1) and increased to 9.8 (1.8) g dl(-1) after transfusion. The mean number of intraoperatively transfused pRBC units was 2.5 (2.7) units (median 2). CONCLUSION: Although European Society of Anaesthesiology transfusion guidelines are moderately implemented in Europe with respect to Hb threshold for transfusion (7-9 g dl(-1)), there is still an urgent need for further educational efforts that focus on the number of pRBC units to be transfused at this threshold. CLINICAL TRIAL REGISTRATION: NCT 01604083

Intraoperative transfusion practices and perioperative outcome in the European elderly: A secondary analysis of the observational ETPOS study

The demographic development suggests a dramatic growth in the number of elderly patients undergoing surgery in Europe. Most red blood cell transfusions (RBCT) are administered to older people, but little is known about perioperative transfusion practices in this population. In this secondary analysis of the prospective observational multicentre European Transfusion Practice and Outcome Study (ETPOS), we specifically evaluated intraoperative transfusion practices and the related outcomes of 3149 patients aged 65 years and older. Enrolled patients underwent elective surgery in 123 European hospitals, received at least one RBCT intraoperatively and were followed up for 30 days maximum. The mean haemoglobin value at the beginning of surgery was 108 (21) g/l, 84 (15) g/l before transfusion and 101 (16) g/l at the end of surgery. A median of 2 [1–2] units of RBCT were administered. Mostly, more than one transfusion trigger was present, with physiological triggers being preeminent. We revealed a descriptive association between each intraoperatively administered RBCT and mortality and discharge respectively, within the first 10 postoperative days but not thereafter. In our unadjusted model the hazard ratio (HR) for mortality was 1.11 (95% CI: 1.08–1.15) and the HR for discharge was 0.78 (95% CI: 0.74–0.83). After adjustment for several variables, such as age, preoperative haemoglobin and blood loss, the HR for mortality was 1.10 (95% CI: 1.05–1.15) and HR for discharge was 0.82 (95% CI: 0.78–0.87). Preoperative anaemia in European elderly surgical patients is undertreated. Various triggers seem to support the decision for RBCT. A closer monitoring of elderly patients receiving intraoperative RBCT for the first 10 postoperative days might be justifiable. Further research on the causal relationship between RBCT and outcomes and on optimal transfusion strategies in the elderly population is warranted. A thorough analysis of different time periods within the first 30 postoperative days is recommended